BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2703404)

  • 1. Pre- and post-irradiation radiosensitization by SR 4233.
    Zeman EM; Brown JM
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):967-71. PubMed ID: 2703404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repair of DNA and chromosome breaks in cells exposed to SR 4233 under hypoxia or to ionizing radiation.
    Wang J; Biedermann KA; Brown JM
    Cancer Res; 1992 Aug; 52(16):4473-7. PubMed ID: 1643639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aerobic radiosensitization by SR 4233 in rodent and human cells: mechanistic and therapeutic implications.
    Zeman EM; Brown JM
    Int J Radiat Biol; 1991 Jan; 59(1):117-31. PubMed ID: 1671059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SR 4233: a tumor specific radiosensitizer active in fractionated radiation regimes.
    Brown JM; Lemmon MJ
    Radiother Oncol; 1991; 20 Suppl 1():151-6. PubMed ID: 2020764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SR-4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells.
    Zeman EM; Brown JM; Lemmon MJ; Hirst VK; Lee WW
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1239-42. PubMed ID: 3744945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual action of tirapazamine in the induction of DNA strand breaks.
    Jones GD; Weinfeld M
    Cancer Res; 1996 Apr; 56(7):1584-90. PubMed ID: 8603406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a CHO cell line resistant to killing by the hypoxic cell cytotoxin SR 4233.
    Giaccia AJ; Biedermann KA; Tosto LM; Minchinton AI; Kovacs MS; Brown JM
    Int J Radiat Oncol Biol Phys; 1992; 22(4):681-4. PubMed ID: 1544836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aerobic radiosensitization by SR 4233 in vitro and in vivo.
    Zeman EM; Lemmon MJ; Brown JM
    Int J Radiat Oncol Biol Phys; 1990 Jan; 18(1):125-32. PubMed ID: 2298615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SR 4233 cytotoxicity and metabolism in DNA repair-competent and repair-deficient cell cultures.
    Biedermann KA; Wang J; Graham RP; Brown JM
    Br J Cancer; 1991 Mar; 63(3):358-62. PubMed ID: 2003976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of radiation-induced tumor cell killing by the hypoxic cell toxin SR 4233.
    Zeman EM; Hirst VK; Lemmon MJ; Brown JM
    Radiother Oncol; 1988 Jul; 12(3):209-18. PubMed ID: 3175048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of hypoxia by measurement of DNA damage in individual cells from spheroids and murine tumours exposed to bioreductive drugs. I. Tirapazamine.
    Olive PL
    Br J Cancer; 1995 Mar; 71(3):529-36. PubMed ID: 7880735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced conversion of DNA radical damage to double strand breaks by 1,2,4-benzotriazine 1,4-dioxides linked to a DNA binder compared to tirapazamine.
    Anderson RF; Harris TA; Hay MP; Denny WA
    Chem Res Toxicol; 2003 Nov; 16(11):1477-83. PubMed ID: 14615975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tirapazamine-induced DNA damage measured using the comet assay correlates with cytotoxicity towards hypoxic tumour cells in vitro.
    Siim BG; van Zijl PL; Brown JM
    Br J Cancer; 1996 Apr; 73(8):952-60. PubMed ID: 8611431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro oxygen-dependent survival of 2 human cell lines after radiation combined with tirapazamine (SR-4233) and cisplatin].
    Lartigau E; Stern S; Guichard M
    Cancer Radiother; 2000; 4(3):217-22. PubMed ID: 10897765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of the benzotriazine dioxide SR 4233 against human tumour colony-forming units.
    Hanauske AR; Ross M; Degen D; Hilsenbeck SG; Von Hoff DD
    Eur J Cancer; 1993; 29A(3):423-5. PubMed ID: 8398345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of radiation and tirapazamine (SR-4233) on three melanoma cell lines.
    Zhang M; Stevens G
    Melanoma Res; 1998 Dec; 8(6):510-5. PubMed ID: 9918413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation by the hypoxic cytotoxin SR 4233 of cell killing produced by fractionated irradiation of mouse tumors.
    Brown JM; Lemmon MJ
    Cancer Res; 1990 Dec; 50(24):7745-9. PubMed ID: 2253217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptation of human tumor cells to tirapazamine under aerobic conditions: implications of increased antioxidant enzyme activity to mechanism of aerobic cytotoxicity.
    Elwell JH; Siim BG; Evans JW; Brown JM
    Biochem Pharmacol; 1997 Jul; 54(2):249-57. PubMed ID: 9271329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective potentiation of the hypoxic cytotoxicity of tirapazamine by its 1-N-oxide metabolite SR 4317.
    Siim BG; Pruijn FB; Sturman JR; Hogg A; Hay MP; Brown JM; Wilson WR
    Cancer Res; 2004 Jan; 64(2):736-42. PubMed ID: 14744792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 5'-iododeoxyuridine on the repair of radiation induced potentially lethal damage interphase chromatin breaks and DNA double strand breaks in Chinese hamster ovary cells.
    Wang Y; Iliakis G
    Int J Radiat Oncol Biol Phys; 1992; 23(2):353-60. PubMed ID: 1587756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.